Hematopoietic Stem Cell Generation via cAMP-Epac Signaling

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for generating hematopoietic stem cells and blood cells in vitro do not adequately provide the necessary molecular signals for homing, self-renewal, proliferation, and differentiation, leading to insufficient numbers of cells with required characteristics for transplantation, particularly in cases where HLA-matched donors are scarce or contaminated with malignant cells.

Innovation Solution

Activation of the cAMP-Epac axis in pluripotent stem cells or reprogrammed cells through culturing with cAMP activators like forskolin, IBMX, norepinephrine, and epinephrine to promote hematopoietic cell generation, which upregulates homing factors like CXCR4 and reduces oxidative stress, enhancing the production of hematopoietic stem cells and erythroid cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional in vitro methods are used to generate hematopoietic cells, then the process is simple and does not require additional signaling molecules, but the number of cells with required characteristics is insufficient for transplantation

Engineering Contradiction:

Improvenumber of hematopoietic cellsVSAvoidcomplexity of culture system

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by introducing specific signaling molecules (cAMP, forskolin, IBMX, norepinephrine, epinephrine) to modify the chemical environment of the culture system. These parameter changes activate the cAMP-Epac axis, which drives hematopoietic differentiation and significantly increases the number of functional hematopoietic cells produced, resolving the contradiction between simplicity and productivity.

Inventive Principle:

Principle #35Parameter changes

2Reliability

If traditional in vitro methods are used, then the culture medium is simple, but the cells lack proper homing factors and oxidative stress protection

Engineering Contradiction:

Improvefunctionality of hematopoietic cellsVSAvoidcomplexity of signaling pathway activation

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses cAMP as an intermediary molecule that mediates the effects of multiple signaling agents (forskolin, IBMX, norepinephrine, epinephrine) through the Epac axis. This intermediary approach ensures reliable production of functional hematopoietic cells with proper homing factors and oxidative stress protection, while organizing the complexity through a unified signaling pathway mechanism.

Inventive Principle:

Principle #24Intermediary (Mediator)

3Productivity

If HSCs are obtained from traditional sources, then the source is readily available, but there is a lack of HLA-matched donors and risk of malignant cell contamination

Engineering Contradiction:

Improveavailability of matched HSCsVSAvoidease of obtaining HSCs

Core Design Contradiction:

ProductivityVSEase of manufacture

Solution Approach 1:

The patent enables self-service by allowing derivation of HSCs from patient-specific pluripotent stem cells that can be differentiated in vitro. This eliminates the need for external donors and avoids malignant cell contamination, as the cells are generated autonomously from the patient's own reprogrammed cells, resolving the contradiction between availability and ease of manufacture.

Inventive Principle:

Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach increases the frequency and functionality of hematopoietic stem cells and erythroid cells, improving their engraftment potential and reducing oxidative damage, thereby addressing the limitations of existing in vitro blood cell generation methods.

Implementation Method 1

Methodology Applied

Scientific EffectcAMP signaling:

Implementation Method 2

Activation of the Exchange proteins activated by cAMP (Epac) axis utilizing cAMP and/or Epac activators

Methodology Applied

Scientific EffectSignal transduction:

Implementation Method 3

which upregulates homing factors like CXCR4

Methodology Applied

Scientific EffectGene expression regulation:

Implementation Method 4

reduces oxidative stress, enhancing the production of hematopoietic stem cells and erythroid cells

Methodology Applied

Scientific EffectOxidative stress reduction: Redox Reactions

Data Source

PatentUS11542473B2Methods and compositions for generating hematopoietic cells

Publication Date: 2023.01.03 AMNIOTICS AB

AI summary

Maturation signals provided via cyclic adenosine monophosphate (cAMP)/Exchange proteins activated by cAMP (Epac) signaling during in vitro generation of blood cells from reprogrammed cells or pluripotent stem cells achieve superior function of hematopoietic cells differentiated from stem cells. The cAMP/Epac signaling enables an increased efficiency of production of precursor to blood and to blood cells. These generated blood cells can be utilized for therapeutics, treatments, disease prevention, drug discovery, personalized medicine, regenerative medicine, cell and tissue generation, universal donor banks and related methods and compositions.